Fundraising Fox

Baymatob

Founded 2017 · 22 employees on LinkedIn · 4 known investors

Baymatob develops Oli, an AI-guided maternal and fetal monitoring platform, including Oli PPH, a device aimed at reducing postpartum hemorrhage, a leading cause of preventable maternal death. The company serves the women's health and maternal healthcare market and has received FDA Breakthrough Device Designation.

AI & Machine LearningFemTechMedical Devices

Investors · 4

Scale Investors✓ verifiedMelbourne · $100K – $3.5M
Alberts Impact VenturesSydney
Even Capital
Pacific ChannelAuckland

In the news

Baymatob raises $6.5M to predict birth complications before they happennews.gsmedtech.com · May 2026Baymatob Secures $1. | Signalbasetrysignalbase.com · May 2026Baymatob Receives MRFF Funding for Oli PPH, an AI-Guided Maternal Health Device | Femtech Insiderfemtechinsider.com · Feb 2024Australian Baymatob Raises $3M for Oli, Its AI-Guided PPH Monitoring Device | Femtech Insiderfemtechinsider.com · Mar 2022MedTech Baymatob completes capital raise to advance life-saving labor monitoring deviceprnewswire.com · Mar 2022MedTech Baymatob completes capital raise to advance life-saving labor monitoring device - BioSpacebiospace.com · Mar 2022

Frequently asked questions

What does Baymatob do?
Baymatob develops Oli, an AI-guided maternal and fetal monitoring platform, including Oli PPH, a device aimed at reducing postpartum hemorrhage, a leading cause of preventable maternal death. The company serves the women's health and maternal healthcare market and has received FDA Breakthrough Device Designation.
Who are Baymatob's investors?
Baymatob's investors include Scale Investors, Alberts Impact Ventures, Even Capital, Pacific Channel.